MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 336.62 Thousand CAD | -10.68% |
| 2022 | 376.87 Thousand CAD | 1.53% |
| 2021 | 371.2 Thousand CAD | -0.15% |
| 2020 | 371.75 Thousand CAD | 56.22% |
| 2019 | 237.96 Thousand CAD | -15.2% |
| 2018 | 280.61 Thousand CAD | 91.64% |
| 2017 | 146.43 Thousand CAD | -18.29% |
| 2016 | 179.2 Thousand CAD | 128.24% |
| 2015 | 78.51 Thousand CAD | -42.74% |
| 2014 | 137.11 Thousand CAD | 25.77% |
| 2013 | 109.01 Thousand CAD | 11.61% |
| 2012 | 97.67 Thousand CAD | -62.27% |
| 2011 | 258.87 Thousand CAD | 63.78% |
| 2010 | 158.06 Thousand CAD | -10.88% |
| 2009 | 177.37 Thousand CAD | -71.99% |
| 2008 | 633.26 Thousand CAD | 103.26% |
| 2007 | 311.55 Thousand CAD | -20.7% |
| 2006 | 392.91 Thousand CAD | -26.56% |
| 2005 | 534.97 Thousand CAD | 12.94% |
| 2004 | 473.69 Thousand CAD | 19.57% |
| 2003 | 396.16 Thousand CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 363.83 Thousand CAD | 8.09% |
| 2024 Q2 | 384.23 Thousand CAD | 5.61% |
| 2023 Q3 | 436.73 Thousand CAD | 4.23% |
| 2023 Q4 | 336.62 Thousand CAD | -22.92% |
| 2023 Q2 | 419 Thousand CAD | -1.26% |
| 2023 Q1 | 424.36 Thousand CAD | 12.6% |
| 2023 FY | 336.62 Thousand CAD | -10.68% |
| 2022 Q4 | 376.87 Thousand CAD | -4.53% |
| 2022 Q1 | 390.65 Thousand CAD | 5.24% |
| 2022 Q2 | 374.07 Thousand CAD | -4.24% |
| 2022 FY | 376.87 Thousand CAD | 1.53% |
| 2022 Q3 | 394.76 Thousand CAD | 5.53% |
| 2021 Q2 | 346.52 Thousand CAD | -6.76% |
| 2021 Q4 | 371.2 Thousand CAD | -2.13% |
| 2021 FY | 371.2 Thousand CAD | -0.15% |
| 2021 Q1 | 371.66 Thousand CAD | -0.02% |
| 2021 Q3 | 379.26 Thousand CAD | 9.45% |
| 2020 Q1 | 255.83 Thousand CAD | 7.51% |
| 2020 Q4 | 371.75 Thousand CAD | 1.9% |
| 2020 FY | 371.75 Thousand CAD | 56.22% |
| 2020 Q2 | 350.92 Thousand CAD | 37.17% |
| 2020 Q3 | 364.82 Thousand CAD | 3.96% |
| 2019 Q4 | 237.96 Thousand CAD | -3.42% |
| 2019 FY | 237.96 Thousand CAD | -15.2% |
| 2019 Q3 | 246.39 Thousand CAD | -7.85% |
| 2019 Q2 | 267.37 Thousand CAD | -8.18% |
| 2019 Q1 | 291.19 Thousand CAD | 3.77% |
| 2018 FY | 280.61 Thousand CAD | 91.64% |
| 2018 Q2 | 229.06 Thousand CAD | 13.43% |
| 2018 Q1 | 201.93 Thousand CAD | 37.9% |
| 2018 Q3 | 275.68 Thousand CAD | 20.35% |
| 2018 Q4 | 280.61 Thousand CAD | 1.79% |
| 2017 FY | 146.43 Thousand CAD | -18.29% |
| 2017 Q1 | 189.04 Thousand CAD | 5.49% |
| 2017 Q2 | 179.62 Thousand CAD | -4.99% |
| 2017 Q4 | 146.43 Thousand CAD | -17.17% |
| 2017 Q3 | 176.77 Thousand CAD | -1.58% |
| 2016 FY | 179.2 Thousand CAD | 128.24% |
| 2016 Q4 | 179.2 Thousand CAD | 35.68% |
| 2016 Q3 | 132.08 Thousand CAD | -6.45% |
| 2016 Q1 | 119.26 Thousand CAD | 51.9% |
| 2016 Q2 | 141.18 Thousand CAD | 18.38% |
| 2015 Q4 | 78.51 Thousand CAD | -53.54% |
| 2015 Q3 | 169.01 Thousand CAD | -2.61% |
| 2015 Q2 | 173.53 Thousand CAD | 34.67% |
| 2015 Q1 | 128.86 Thousand CAD | -6.02% |
| 2015 FY | 78.51 Thousand CAD | -42.74% |
| 2014 FY | 137.11 Thousand CAD | 25.77% |
| 2014 Q3 | 139.31 Thousand CAD | -0.33% |
| 2014 Q4 | 137.11 Thousand CAD | -1.58% |
| 2014 Q2 | 139.77 Thousand CAD | 11.39% |
| 2014 Q1 | 125.47 Thousand CAD | 15.1% |
| 2013 Q3 | 123.03 Thousand CAD | 1.07% |
| 2013 Q2 | 121.73 Thousand CAD | 16.23% |
| 2013 Q1 | 104.73 Thousand CAD | 7.22% |
| 2013 Q4 | 109.01 Thousand CAD | -11.4% |
| 2013 FY | 109.01 Thousand CAD | 11.61% |
| 2012 Q2 | 244.05 Thousand CAD | -1.72% |
| 2012 Q3 | 231.85 Thousand CAD | -5.0% |
| 2012 Q4 | 97.67 Thousand CAD | -57.87% |
| 2012 FY | 97.67 Thousand CAD | -62.27% |
| 2012 Q1 | 248.31 Thousand CAD | -4.08% |
| 2011 Q3 | 217.8 Thousand CAD | 9.7% |
| 2011 FY | 258.87 Thousand CAD | 63.78% |
| 2011 Q4 | 258.87 Thousand CAD | 18.86% |
| 2011 Q2 | 198.54 Thousand CAD | 42.16% |
| 2011 Q1 | 139.66 Thousand CAD | -11.64% |
| 2010 Q2 | 134.56 Thousand CAD | 0.61% |
| 2010 Q4 | 158.06 Thousand CAD | 8.78% |
| 2010 FY | 158.06 Thousand CAD | -10.88% |
| 2010 Q3 | 145.31 Thousand CAD | 7.99% |
| 2010 Q1 | 133.75 Thousand CAD | -24.59% |
| 2009 Q3 | 578.73 Thousand CAD | -0.97% |
| 2009 Q4 | 177.37 Thousand CAD | -69.35% |
| 2009 Q1 | 608.92 Thousand CAD | -3.84% |
| 2009 FY | 177.37 Thousand CAD | -71.99% |
| 2009 Q2 | 584.41 Thousand CAD | -4.03% |
| 2008 Q1 | 365.64 Thousand CAD | 17.36% |
| 2008 Q2 | 478.9 Thousand CAD | 30.97% |
| 2008 FY | 633.26 Thousand CAD | 103.26% |
| 2008 Q3 | 498.72 Thousand CAD | 4.14% |
| 2008 Q4 | 633.26 Thousand CAD | 26.98% |
| 2007 Q1 | 399.78 Thousand CAD | 1.75% |
| 2007 Q2 | 383.08 Thousand CAD | -4.18% |
| 2007 Q3 | 337.99 Thousand CAD | -11.77% |
| 2007 Q4 | 311.55 Thousand CAD | -7.82% |
| 2007 FY | 311.55 Thousand CAD | -20.7% |
| 2006 Q3 | 370.37 Thousand CAD | -5.39% |
| 2006 Q4 | 392.91 Thousand CAD | 6.08% |
| 2006 Q2 | 391.48 Thousand CAD | -33.0% |
| 2006 Q1 | 584.32 Thousand CAD | 9.22% |
| 2006 FY | 392.91 Thousand CAD | -26.56% |
| 2005 Q2 | 765.87 Thousand CAD | 32.05% |
| 2005 Q4 | 534.97 Thousand CAD | -34.04% |
| 2005 Q3 | 811.11 Thousand CAD | 5.91% |
| 2005 Q1 | 580 Thousand CAD | 22.44% |
| 2005 FY | 534.97 Thousand CAD | 12.94% |
| 2004 Q4 | 473.69 Thousand CAD | 0.0% |
| 2004 FY | 473.69 Thousand CAD | 19.57% |
| 2003 FY | 396.16 Thousand CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AVITA Medical, Inc. | 3.12 Million USD | 89.216% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.753% |
| QHSLab, Inc. | 25.18 Thousand USD | -1236.809% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.753% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 1.61 Million USD | 79.132% |
| Aurora Spine Corporation | 3.54 Million USD | 90.502% |
| BrainsWay Ltd. | 3.71 Million USD | 90.944% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 41.05 Thousand USD | -719.989% |
| Hamilton Thorne Ltd. | 14.36 Million USD | 97.657% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 46.22 Thousand USD | -628.193% |
| REMSleep Holdings, Inc. | 99.14 Thousand USD | -239.518% |
| Zecotek Photonics Inc. | 94.9 Thousand USD | -254.712% |
| Avitar, Inc. | 225.15 Thousand USD | -49.506% |
| Nanomix Corporation | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 11.15 Million USD | 96.983% |
| Theraclion SA | 3.05 Million EUR | 88.98% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.25 Million USD | 73.217% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 68.51 Thousand USD | -391.297% |
| Lombard Medical, Inc. | 6.87 Million USD | 95.105% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 157.55 Million USD | 99.786% |
| Vycor Medical, Inc. | 234.14 Thousand USD | -43.766% |
| Heart Tronics, Inc. | 163.85 Thousand USD | -105.438% |
| MicroPort Scientific Corporation | 414.75 Million USD | 99.919% |
| VMS Rehab Systems, Inc. | 1.33 USD | -25309824.812% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 632 Thousand USD | 46.737% |
| Ingen Technologies, Inc. | 85.59 Thousand USD | -293.278% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 12.19 Thousand USD | -2661.46% |
| Wellness Center USA, Inc. | 125.67 Thousand USD | -167.843% |
| SANUWAVE Health, Inc. | 2.95 Million USD | 88.593% |
| IR-Med Inc. | -81.00 USD | 415682.716% |
| Perimeter Medical Imaging AI, Inc. | 128.99 Thousand USD | -160.949% |
| Polarean Imaging plc | 2.21 Million USD | 84.828% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 313.4 Thousand USD | -7.407% |
| Medical Supply International USA, Inc. | 29.3 Thousand USD | -1048.685% |
| Urologix, Inc. | 1.39 Million USD | 75.904% |
| Rapid Therapeutic Science Laboratories, Inc. | 175.04 Thousand USD | -92.304% |
| Nexeon MedSystems Inc. | 2.2 Million USD | 84.745% |
| SS Innovations International, Inc. | 6.32 Million USD | 94.68% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.986% |
| NIOX Group Plc | 6.11 Million USD | 94.491% |
| Fuse Medical, Inc. | 9.11 Million USD | 96.309% |
| Broncus Holding Corporation | 4.7 Million USD | 92.85% |
| Brain Scientific Inc. | 149.55 Thousand USD | -125.078% |
| Pressure BioSciences, Inc. | 304.9 Thousand USD | -10.401% |
| Health Logic Interactive Inc. | -4511.80 USD | 7560.925% |